Nylia 7/7/7 Kit
Product Images NDC 65862-897

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Nylia 7/7/7 (NDC 65862-897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Norethindrone Fig1)

A bar chart illustrating circulatory disease mortality rates per 100,000 woman-years categorized by age groups (15-24, 25-34, 35-44, 45+) and subdivided by smoking status and oral contraceptive use. Mortality rates for ever-users and controls are compared in both non-smokers and smokers, showing increasing rates with age, especially higher in smokers who are ever-users aged 45 and older.*

FDA Label Image

Figure 2 (Norethindrone Fig2)

A horizontal error bar chart showing effect estimates (odds ratios or relative risks) with confidence intervals from various contraceptive use studies, including the NICHD Women's Contraceptive Study, French E3N cohort study, and others between 2002 and 2017. The x-axis represents effect estimates ranging from -1.5 to 2.*

FDA Label Image

Figure 3 (Norethindrone Fig3)

An instructional diagram showing the color coding for Nylia 7/7/7 tablets by week and day of the week. It displays four rows labeled Week 1 through Week 4, with circles representing tablets in different colors: white to off-white for Week 1, light peach for Week 2, peach for Week 3, and green for Week 4, arranged from Sunday to Saturday. The diagram includes the full product name and active ingredient strengths at the bottom.*

FDA Label Image

Figure 4 (Norethindrone Fig4)

An instructional illustration showing how to apply the correct day label to a Nylia 7/7/7 oral contraceptive pill kit. It depicts a hand peeling a day-of-week label to place on the blister pack, which contains four rows of pills in different colors (white to off-white, light peach, peach, and green) organized by week. The diagram includes instructions to select the label starting with the correct day and outlines the pill colors by week.*

FDA Label Image

Figure 5 (Norethindrone Fig5)

Instructional diagram for Nylia 7/7/7 kit showing how to apply the correct day label to the tablet pack. The image includes a hand placing a peel-and-place day label on the pack, with rows of circles indicating tablets for White to off-white, Light Peach, Peach, and Green corresponding to weeks 1 through 4. The day labels for MON through SUN are shown at the top for selection.*

FDA Label Image

Figure 6 (Norethindrone Fig6)

A tablet calendar diagram for Nylia 7/7/7 oral contraceptive kit showing a 4-week dosing schedule arranged by day of the week. Circles are color-coded by week to represent different tablet types: white to off-white for week 1, light peach for week 2, peach for week 3, and green for week 4. Each circle corresponds to one day's dose, with arrows indicating the weekly progression.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg/0.035 mg, 0.75 mg/0.035 mg and 1 mg/0.035 mg Pouch Label)

An instructional illustration for the Nylia 7/7/7 oral contraceptive kit showing how to place the correct day label on the blister pack. The image includes a hand applying a peel-and-place label with day names (MON, TUE, WED, THU, FRI, SAT, SUN) atop the blister containing four rows of circular pills in white to off-white, light peach, peach, and green colors, each row representing a week of the 28-day cycle.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg/0.035 mg, 0.75 mg/0.035 mg and 1 mg/0.035 mg Pouch Carton)

Label for Nylia 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP) kit, containing a 28-day regimen with strengths 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, and 1 mg/0.035 mg. The label states Rx only, with 1 pouch of 28 tablets, distributed by Aurobindo Pharma Limited.*

FDA Label Image

Norethindrone Fig9

Nylia 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP) kit with a 28-day regimen. Contains 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, and 1 mg/0.035 mg strengths. The package includes 6 pouches each containing 28 tablets. Distributed by Aurobindo Pharma USA, Inc., the label includes storage instructions and warnings, specifying Rx only and that the product is not protective against HIV/AIDS.*

FDA Label Image

Chemical Structure (Norethindrone Str)

Chemical structure diagrams of Norethindrone and Ethinyl Estradiol, the active ingredients in Nylia 7/7/7. The image shows the molecular forms of both steroid hormones side by side, labeled clearly with their names.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.